Results 201 to 210 of about 143,361 (253)

Initial Vancomycin Taper for the Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

JAMA Netw Open
McDonald EG, Butler-Laporte G, Brophy JM, Elsayed S, Frenette C, Huseen I, Loo VG, Moran K, Coburn B, Hota SS, Longtin Y, Kong LY, Muller MP, Steiner TS, Valiquette L, Daneman N, Daley P, Nott C, MacFadden DR, Kandel CE, Chen Y, Perez-Patrigeon S, Lee TC, TAPER-V Team.   +23 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clostridioides difficile

Molecular Typing in Bacterial Infections, Volume II, 2022
Glenn Tillotson, P. Feuerstadt, N. Theriault   +2 more
semanticscholar   +3 more sources

Clostridioides difficile

Journal of Pediatric Surgical Nursing, 2022
Abstract The purpose of this article is to present an exemplar related to diagnostic testing whereby reasoned decisions can assist the pediatric surgical clinician in the expeditious screening, diagnosis, and management of Clostridioides difficile infection (CDI). In 2017, the Emerging Infections Program for CDI reported that the incidence of
Raquel Pasarón, Juan L. Calisto
openaire   +1 more source

The future of Clostridioides difficile diagnostics

Current Opinion in Infectious Diseases, 2021
Purpose of review Although the epidemiology of Clostridioides difficile has changed, this organism continues to cause significant morbidity and mortality. This review addresses current and future approaches to the diagnosis of C. difficile disease.
Masako, Mizusawa, Karen C, Carroll
openaire   +2 more sources

Clostridioides difficile colitis

2021
Clostridioides difficile (C. diff) is the most frequently reported nosocomial pathogen and a leading cause of morbidity and mortality in hospitalized patients. In the USA 435,000 infections are annually reported, with 29,000 deaths. C. diff infection quadruples hospitalization costs.
openaire   +1 more source

Antimicrobial resistance in Clostridioides difficile

European Journal of Clinical Microbiology & Infectious Diseases, 2021
Antimicrobial resistance (AMR) in Clostridioides difficile remains a significant threat to global healthcare systems, not just for the treatment of C. difficile infection (CDI), but as a reservoir of AMR genes that could be potentially transferred to other pathogens. The mechanisms of resistance for several antimicrobials such as metronidazole and MLSB-
O'Grady, K., Knight, D.R., Riley, T.V.
openaire   +2 more sources

Clostridioides difficile Colitis

Surgical Clinics of North America
Clostridioides difficile colitis is an important source of hospital-acquired diarrhea associated with antibiotic use. Symptoms are profuse watery diarrhea, typically following a course of antibiotics; however, some cases of fulminant disease may manifest with shock, ileus, or megacolon. Nonfulminant colitis is treated with oral fidaxomicin. C difficile
Luke, Pumiglia, Lexi, Wilson, Laila, Rashidi   +2 more
openaire   +3 more sources

Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options

Clinical Microbiology Reviews
SUMMARY Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections. This bacterium is constantly evolving and poses complex challenges for clinicians, often encountered in real-life scenarios.
Stefano Di Bella, Gianfranco Sanson, J. Monticelli, V. Zerbato, Luigi Principe, Mauro Giuffrè, G. Pipitone, R. Luzzati   +7 more
semanticscholar   +1 more source